[go: up one dir, main page]

NO982097D0 - Peptider - Google Patents

Peptider

Info

Publication number
NO982097D0
NO982097D0 NO982097A NO982097A NO982097D0 NO 982097 D0 NO982097 D0 NO 982097D0 NO 982097 A NO982097 A NO 982097A NO 982097 A NO982097 A NO 982097A NO 982097 D0 NO982097 D0 NO 982097D0
Authority
NO
Norway
Prior art keywords
peptides
Prior art date
Application number
NO982097A
Other languages
English (en)
Other versions
NO315238B1 (no
NO982097L (no
Inventor
Gustav Gaudernack
Ingvil Saeterdal
Jon Amund Eriksen
Mona Moeller
Marianne Klemp Gjertsen
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO19982097A priority Critical patent/NO315238B1/no
Publication of NO982097D0 publication Critical patent/NO982097D0/no
Priority to PCT/NO1999/000143 priority patent/WO1999058552A2/en
Priority to AU54516/99A priority patent/AU755712B2/en
Priority to EP10183767.2A priority patent/EP2374814B1/en
Priority to JP2000548356A priority patent/JP4591983B2/ja
Priority to PL99344341A priority patent/PL344341A1/xx
Priority to US09/674,973 priority patent/US6759046B1/en
Priority to CA2327549A priority patent/CA2327549C/en
Priority to EP99940722.4A priority patent/EP1078000B1/en
Priority to CNB998073555A priority patent/CN100355781C/zh
Priority to ES10183767.2T priority patent/ES2463825T3/es
Priority to HK01107827.3A priority patent/HK1036997B/xx
Priority to HU0101432A priority patent/HUP0101432A3/hu
Priority to ARP990102199A priority patent/AR018346A1/es
Publication of NO982097L publication Critical patent/NO982097L/no
Publication of NO315238B1 publication Critical patent/NO315238B1/no
Priority to US10/776,224 priority patent/US7192927B2/en
Priority to US11/498,194 priority patent/US7863244B2/en
Priority to US12/983,510 priority patent/US8614177B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19982097A 1998-05-08 1998-05-08 Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy NO315238B1 (no)

Priority Applications (17)

Application Number Priority Date Filing Date Title
NO19982097A NO315238B1 (no) 1998-05-08 1998-05-08 Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
HU0101432A HUP0101432A3 (en) 1998-05-08 1999-05-03 Peptides that ellicit, cellular immunity
EP99940722.4A EP1078000B1 (en) 1998-05-08 1999-05-03 Peptides that ellicit t cellular immunity
ES10183767.2T ES2463825T3 (es) 1998-05-08 1999-05-03 Péptidos que provocan inmunidad celular T
EP10183767.2A EP2374814B1 (en) 1998-05-08 1999-05-03 Peptides that ellicit T cellular immunity
JP2000548356A JP4591983B2 (ja) 1998-05-08 1999-05-03 ペプチド
PL99344341A PL344341A1 (en) 1998-05-08 1999-05-03 Peptides
US09/674,973 US6759046B1 (en) 1998-05-08 1999-05-03 Peptides
CA2327549A CA2327549C (en) 1998-05-08 1999-05-03 Peptides that induce t cell responses
PCT/NO1999/000143 WO1999058552A2 (en) 1998-05-08 1999-05-03 Peptides that ellicit t, cellular immunity
CNB998073555A CN100355781C (zh) 1998-05-08 1999-05-03 肽
AU54516/99A AU755712B2 (en) 1998-05-08 1999-05-03 Peptides
HK01107827.3A HK1036997B (en) 1998-05-08 1999-05-03 Peptides
ARP990102199A AR018346A1 (es) 1998-05-08 1999-05-10 Peptidos mutantes promotores de la inmunidad celular t, composiciones farmaceuticas y vacunas formuladas con dichos peptidos para el tratamiento decanceres; uso de dichos peptidos, metodo para identificar dichos peptidos y secuencias de adn que codifican dichos peptidos mutantes y vectores y plasmid
US10/776,224 US7192927B2 (en) 1998-05-08 2004-02-12 Peptides
US11/498,194 US7863244B2 (en) 1998-05-08 2006-08-03 Peptides
US12/983,510 US8614177B2 (en) 1998-05-08 2011-01-03 Peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO19982097A NO315238B1 (no) 1998-05-08 1998-05-08 Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy

Publications (3)

Publication Number Publication Date
NO982097D0 true NO982097D0 (no) 1998-05-08
NO982097L NO982097L (no) 1999-11-09
NO315238B1 NO315238B1 (no) 2003-08-04

Family

ID=19902021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982097A NO315238B1 (no) 1998-05-08 1998-05-08 Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy

Country Status (12)

Country Link
US (4) US6759046B1 (no)
EP (2) EP1078000B1 (no)
JP (1) JP4591983B2 (no)
CN (1) CN100355781C (no)
AR (1) AR018346A1 (no)
AU (1) AU755712B2 (no)
CA (1) CA2327549C (no)
ES (1) ES2463825T3 (no)
HU (1) HUP0101432A3 (no)
NO (1) NO315238B1 (no)
PL (1) PL344341A1 (no)
WO (1) WO1999058552A2 (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO314086B1 (no) 1998-05-08 2003-01-27 Gemvax As Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
GB2361701A (en) * 2000-04-28 2001-10-31 Norsk Hydro As DNA polymerase delta mutants
GB0031430D0 (en) 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
EP1430904A4 (en) * 2001-08-29 2005-09-14 Greenpeptide Co Ltd desensitisers
US6984645B2 (en) 2001-11-16 2006-01-10 Bristol-Myers Squibb Company Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
EP1369126A1 (en) * 2002-04-18 2003-12-10 MTM Laboratories AG Use of coding microsatellite region frameshift mutation-derived peptides for treating cancer
US8053552B2 (en) 2002-04-18 2011-11-08 Mtm Laboratories, Ag Neopeptides and methods useful for detection and treatment of cancer
US20050221350A1 (en) * 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
CA2898163C (en) * 2002-12-16 2016-10-11 Globeimmune, Inc. Yeast-based vaccines as immunotherapy
US7439042B2 (en) * 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
US8343502B2 (en) * 2002-12-16 2013-01-01 Globeimmune, Inc. Yeast-based vaccines as immunotherapy
CN102558334B (zh) * 2004-09-07 2016-08-03 伯纳姆研究院 选择性锚定到心脏脉管系统上的肽和相关结合物和方法
US7501486B2 (en) 2004-09-07 2009-03-10 Burnham Institute For Medical Research Peptides that selectively home to heart vasculature and related conjugates and methods
EP1809773B1 (en) * 2004-10-18 2014-07-16 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis c infection
EP2371381A3 (en) * 2005-07-11 2012-07-18 Globeimmune, Inc. Compositions and methods for eliciting an immune response to escape mutants of targeted therapies
EP1994181A4 (en) * 2006-02-27 2010-05-19 Univ Arizona IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
CA2926004A1 (en) 2006-08-11 2008-02-14 Life Sciences Research Partners Vzw Immunogenic peptides and their use in allergic and autoimmune disorders
RU2505313C2 (ru) * 2007-03-19 2014-01-27 Глоубиммьюн, Инк. Композиции и способы направленного устранения мутационного ускользания в направленной терапии рака
US20080293050A1 (en) * 2007-05-25 2008-11-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Gene analysis for determination of a treatment characteristic
US20120009678A1 (en) 2008-02-14 2012-01-12 Jean-Marie Saint-Remy Immunotherapy targeting intracellular pathogens
EP2623124A1 (en) 2008-02-14 2013-08-07 Life Sciences Research Partners VZW Elimination of immune responses to viral vectors
EP2247306B1 (en) 2008-02-14 2018-04-18 Life Sciences Research Partners VZW Immunogenic control of tumours and tumour cells
AU2009214041A1 (en) 2008-02-14 2009-08-20 Katholieke Universiteit Leuven CD4+ T-cells with cytolytic properties
PL2249864T3 (pl) * 2008-02-14 2016-11-30 Strategie zapobiegania i/lub leczenia odpowiedzi immunologicznych na rozpuszczalne alloczynniki
CA2715517C (en) * 2008-02-14 2018-07-24 Life Sciences Research Partners Vzw Immunogenic peptides and their use in preventing or treating allograft rejection
EP2331125A4 (en) 2008-09-19 2013-03-27 Globeimmune Inc IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
US20100260739A1 (en) 2009-03-09 2010-10-14 Bioatla, Llc Mirac Proteins
ES2924027T3 (es) 2010-11-25 2022-10-04 Imcyse Sa Péptidos inmunogénicos para su uso en la prevención y/o tratamiento de enfermedades infecciosas, enfermedades autoinmunitarias, respuestas inmunitarias a alofactores, enfermedades alérgicas, tumores, rechazo de injerto y respuestas inmunitarias contra vectores virales usados para terapia génica o vacunación génica
IN2014CN03922A (no) * 2011-10-28 2015-09-04 Oncotherapy Science Inc
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
EP2834264A1 (en) * 2012-04-04 2015-02-11 Yeda Research and Development Co. Ltd. Lipopeptide conjugates comprising sphingolipid and hiv gp41 derived peptides
JP5890769B2 (ja) * 2012-12-13 2016-03-22 ループレヒト−カルルス・ウニヴェルジテート・ハイデルベルクＲｕｐｒｅｃｈｔ−Ｋａｒｌｓ−Ｕｎｉｖｅｒｓｉｔａｅｔ Ｈｅｉｄｅｌｂｅｒｇ がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）
US9205140B2 (en) 2012-12-13 2015-12-08 Ruprecht-Karls-Universität MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
GB201418433D0 (en) 2014-10-17 2014-12-03 Imcyse Sa Novel immunogenic peptides
JP6863893B2 (ja) * 2014-11-26 2021-04-21 アメリカ合衆国 抗突然変異ｋｒａｓ ｔ細胞受容体
AU2016260540B2 (en) 2015-05-13 2021-01-07 Agenus Inc. Vaccines for treatment and prevention of cancer
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
JP2016028025A (ja) * 2015-07-29 2016-02-25 ループレヒト−カルルス・ウニヴェルジテート・ハイデルベルクＲｕｐｒｅｃｈｔ−Ｋａｒｌｓ−Ｕｎｉｖｅｒｓｉｔａｅｔ Ｈｅｉｄｅｌｂｅｒｇ がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）
EP3352782B1 (en) 2015-09-25 2021-03-31 ImCyse SA Improved methods and compounds for eliminating immune responses to therapeutic agents
US11634470B2 (en) * 2015-10-23 2023-04-25 Jai Prakash Integrin binding peptides and uses thereof
JP2019505512A (ja) 2016-01-08 2019-02-28 バッシボディ アクスイェ セルスカプ 治療用抗癌ネオエピトープワクチン
JP6903680B2 (ja) * 2016-03-15 2021-07-14 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 膵管腺ガンを有する被験体のリスクを評価するための早期かつ非侵襲的な方法及びこのような疾患の処置方法
JP2019513373A (ja) * 2016-03-31 2019-05-30 ネオン セラピューティクス， インコーポレイテッド ネオ抗原およびその使用方法
KR20240015731A (ko) 2016-04-19 2024-02-05 임시스 에스에이 신규 면역원성 CD1d 결합 펩티드
GB201608052D0 (en) * 2016-05-09 2016-06-22 Univ Oslo Hf T-cell receptors which recognise frameshift mutants of TGF-beta RII
EP3503908A1 (en) * 2016-08-23 2019-07-03 The Cleveland Clinic Foundation Cancer treatment using cx26 blocking peptides
CN108503690B (zh) * 2017-02-28 2020-07-03 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
WO2018157773A1 (zh) * 2017-02-28 2018-09-07 暨南大学 一种促进创伤后组织修复与再生的修复肽及其应用
EP3630131B1 (en) * 2017-06-02 2022-08-31 Arizona Board of Regents on behalf of Arizona State University A method to create personalized canine cancer vaccines
WO2019055618A1 (en) 2017-09-15 2019-03-21 Arizona Board Of Regents On Behalf Of Arizona State University METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY
KR20210005646A (ko) 2018-04-26 2021-01-14 아게누스 인코포레이티드 열쇼크 단백질-결합 펩티드 조성물 및 그의 이용 방법
EP3827265A1 (en) 2018-07-26 2021-06-02 Frame Pharmaceuticals B.V. Cancer vaccines for kidney cancer
US20210252123A1 (en) 2018-07-26 2021-08-19 Frame Pharmaceuticals B.V. ARID1A, CDKN2A, KMT2B, KMT2D, TP53 and PTEN VACCINES FOR CANCER
WO2020022901A1 (en) 2018-07-26 2020-01-30 Frame Pharmaceuticals B.V. Cancer vaccines for uterine cancer
IL321692A (en) 2018-07-26 2025-08-01 Curevac Netherlands B V Cancer vaccines for colorectal cancer
EP3827262A1 (en) 2018-07-26 2021-06-02 Frame Pharmaceuticals B.V. Cancer vaccines for breast cancer
HRP20240017T1 (hr) * 2019-05-29 2024-04-26 Hubro Therapeutics As Peptidi
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer
CN110734474B (zh) * 2019-11-29 2021-10-19 中山大学 一种抗菌肽的筛选方法及其应用
CN113061165A (zh) * 2020-01-02 2021-07-02 厦门大学 EB病毒BNLF2b基因编码多肽及其检测用途
EP4087389A4 (en) * 2020-01-09 2024-02-21 Arizona Board of Regents on behalf of Arizona State University Antibodies and method of producing antibodies
KR20230019859A (ko) 2020-05-28 2023-02-09 휴브로 테라퓨틱스 에이에스 펩타이드 칵테일
WO2024052542A2 (en) 2022-09-09 2024-03-14 Hubro Therapeutics As A peptide cocktail

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103974D0 (en) 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
US5700638A (en) * 1993-08-26 1997-12-23 Washington University Cell death regulator
GB9410922D0 (en) * 1994-06-01 1994-07-20 Townsend Alain R M Vaccines
EP0793501A4 (en) 1994-12-14 2000-05-03 Scripps Research Inst IN VIVO ACTIVATION OF TUMOR SPECIFIC CYTOTOXIC T CELLS
US5866323A (en) * 1995-04-07 1999-02-02 Case Western Reserve University Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors
WO1997012992A2 (en) 1995-10-02 1997-04-10 Royal Netherlands Academy Of Arts And Sciences Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore
US5973018A (en) * 1995-10-04 1999-10-26 Owens-Corning Fiberglas Technology, Inc. Process for producing shaped phenolic foams
US5840839A (en) 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
WO1998015285A1 (en) 1996-10-10 1998-04-16 The Wistar Institute Of Anatomy And Biology Methods and compositions for inducing a protective immune response to cancers
GB2328689A (en) * 1997-08-27 1999-03-03 Norsk Hydro As Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
NO314086B1 (no) 1998-05-08 2003-01-27 Gemvax As Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides

Also Published As

Publication number Publication date
JP2002519999A (ja) 2002-07-09
US6759046B1 (en) 2004-07-06
US20050074849A1 (en) 2005-04-07
HUP0101432A2 (hu) 2001-08-28
CN100355781C (zh) 2007-12-19
US7863244B2 (en) 2011-01-04
NO315238B1 (no) 2003-08-04
EP2374814A3 (en) 2012-01-11
CA2327549C (en) 2014-10-07
AU5451699A (en) 1999-11-29
WO1999058552A3 (en) 2000-03-02
HK1036997A1 (zh) 2002-01-25
ES2463825T3 (es) 2014-05-29
EP2374814A2 (en) 2011-10-12
NO982097L (no) 1999-11-09
JP4591983B2 (ja) 2010-12-01
PL344341A1 (en) 2001-11-05
AR018346A1 (es) 2001-11-14
CN1305495A (zh) 2001-07-25
CA2327549A1 (en) 1999-11-18
HUP0101432A3 (en) 2004-01-28
EP2374814B1 (en) 2014-03-19
US8614177B2 (en) 2013-12-24
AU755712B2 (en) 2002-12-19
EP1078000B1 (en) 2017-03-29
US7192927B2 (en) 2007-03-20
US20070004632A1 (en) 2007-01-04
EP1078000A2 (en) 2001-02-28
WO1999058552A2 (en) 1999-11-18
US20110105721A1 (en) 2011-05-05

Similar Documents

Publication Publication Date Title
NO982097D0 (no) Peptider
NO982098D0 (no) Peptider
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
ATE341990T1 (de) Sigmidoskop
DE59911453D1 (de) Aktivkohlefilter
DE59902874D1 (de) Buchsenkontakt
DE59901560D1 (de) Retrograder tibianagel
IS5585A (is) Lyfjaskömmtunarbúnaðir
DE59907306D1 (de) Fadenchangierung
DE59906931D1 (de) Exzenterzahnradgetriebe
NO20001494D0 (no) Overligger
ATE262513T1 (de) Benzoylpyridazine
DE59903966D1 (de) Exzenterzahnradgetriebe
NO20006028L (no) Spenningsomkoblingsanordning
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59908057D1 (de) Underdruckhandhabungseinrichung
ATE295417T1 (de) Angiostatin-bindendes protein
FR2791348B1 (fr) POLYPEPTIDE Npt2B
DE59808995D1 (de) Endomikroskopsystem
DE19842103B4 (de) Stanznietzuführung
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
DE59902088D1 (de) Achrathermer Reimager
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DE59903616D1 (de) Rollenwicklerwalze

Legal Events

Date Code Title Description
MK1K Patent expired